3 Biotech Stocks to Watch: QBioMed Inc, Seattle Genetics and Jazz Pharmaceuticals

2018 turned out to be superb for the pharma and biotech sector with the FDA approval of 59 drugs compared to only 46 drugs approved in 2017. Some investors like the idea of stepping in small-cap biotech stocks that are in the development or preclinical stage, hoping to ride the next multi-baggers if those companies […]

Seattle Genetics Q3 Loss Narrows, Lowers FY2012 Sales Guidance Of Adcetris (SGEN)

Following a downgrade from “hold” to “sell” by Cantor Fitzgerald, the shares of biotechnology company Seattle Genetics (NASDAQ: SGEN) dropped sharply by over 13% at the opening of yesterday’s trading session. Earlier on Wednesday evening, after the market closed, Seattle Genetics reported a rise in the fiscal 2012 third-quarter revenues and a narrowed net loss […]